Physics, Safety, Devices, Methodology
Cardiovascular magnetic resonance physics for clinicians: part I
Ridgway JP. J Cardiovasc Magn Reson. 2010 Nov 30;12:71. doi: 10.1186/1532-429X-12-71.
Cardiovascular magnetic resonance physics for clinicians: Part II
Biglands JD, Radjenovic A, Ridgway JP. J Cardiovasc Magn Reson. 2012 Sep 20;14:66. doi: 10.1186/1532-429X-14-66.
http://www.mrisafety.com/TMDL_list.php
Official web site of the Institute For Magnetic Resonance Safety, Education, And Research.
MR labeling information for implants and devices: explanation of terminology
Shellock FG, Woods TO, Crues JV 3rd. Radiology. 2009 Oct;253(1):26-30. doi: 10.1148/radiol.2531091030.
A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices
Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo AC, Caffo BS, Frick KD, Kraut MA, Kamel IR, Calkins H, Berger RD, Bluemke DA, Halperin HR. Ann Intern Med. 2011 Oct 4;155(7):415-24. doi: 10.7326/0003-4819-155-7-201110040-00004.
Magnetic resonance imaging and implantable devices
Nazarian S, Beinart R, Halperin HR. Circ Arrhythm Electrophysiol. 2013 Apr;6(2):419-28. doi: 10.1161/CIRCEP.113.000116. Review. No abstract available.
https://www.ema.europa.eu/en/documents/press-release/european-medicines-agency-makes-recommendations-minimise-risk-nephrogenic-systemic-fibrosis_en.pdfEuropean Medicines Agency; review of the risk of nephrogenic systemic fibrosis in patients receiving gadolinium containing contrast agents. 2010. Doc. Ref. EMEA/727399/2009 rev. EMEA/H/A-31/1097.
https://www.gov.uk/government/publications/safety-guidelines-for-magnetic-resonance-imaging-equipment-in-clinical-use
Medicines and Healthcare products Regulatory Agency (MHRA) Device Bulletin Safety Guidelines for Magnetic Resonance Imaging Equipment in Clinical Use. March 2015.
2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry
Bruder O, Schneider S, Pilz G, van Rossum AC, Schwitter J, Nothnagel D, Lombardi M, Buss S, Wagner A, Petersen S, Greulich S, Jensen C, Nagel E, Sechtem U, Mahrholdt H. J Cardiovasc Magn Reson. 2015 Jul 14;17:58. doi: 10.1186/s12968-015-0168-3.
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents
American College of Cardiology Foundation Task Force on ExpertConsensus Documents, Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, Friedrich MG, Ho VB, Jerosch-Herold M, Kramer CM, Manning WJ, Patel M, Pohost GM, Stillman AE, White RD, Woodard PK. J Am Coll Cardiol. 2010 Jun 8;55(23):2614-62. doi: 10.1016/j.jacc.2009.11.011
Quantification of LV function and mass by cardiovascular magnetic resonance: multi-center variability and consensus contours
Suinesiaputra A, Bluemke DA, Cowan BR, Friedrich MG, Kramer CM, Kwong R, Plein S, Schulz-Menger J, Westenberg JJ, Young AA, Nagel E. J Cardiovasc Magn Reson. 2015 Jul 28;17(1):63. doi: 10.1186/s12968-015-0170-9.
Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update
Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E; Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. J Cardiovasc Magn Reson. 2013 Oct 8;15:91. doi: 10.1186/1532-429X-15-91.
2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR appropriate utilization of cardiovascular imaging in heart failure: a joint report of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Foundation Appropriate Use Criteria Task Force
Patel MR, White RD, Abbara S, Bluemke DA, Herfkens RJ, Picard M, Shaw LJ, Silver M, Stillman AE, Udelson J; American College of Radiology Appropriateness Criteria Committee; American College of Cardiology Foundation Appropriate Use Criteria Task Force. J Am Coll Cardiol. 2013 May 28;61(21):2207-31. doi: 10.1016/j.jacc.2013.02.005. Epub 2013 Apr 23.
Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology
von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. J Cardiovasc Magn Reson. 2016 Jan 22;18:6. doi: 10.1186/s12968-016-0225-6.
Normal values for cardiovascular magnetic resonance in adults and children
Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, Vogel-Claussen J, Turkbey EB, Williams R, Plein S, Tee M, Eng J, Bluemke DA.
J Cardiovasc Magn Reson. 2015 Apr 18;17:29. doi: 10.1186/s12968-015-0111-7.
Ischaemic Heart Disease
The Use of Contrast Enhanced MRI to Identify Reversible Myocardial Dysfunction
Kim RJ et al, N Engl J Med 2000;343: 1445-53
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age and contractile function
Kim RJ et al, Circulation 1999;100:1992-02.
Prognostic significance of microvascular obstruction by CMR in patients with acute myocardial infarction
Wu KC, et al, Circulation. 1998;97:765-72.
Microvascular obstruction and left ventricular remodeling early after acute MI
Gerber BL, et al, Circulation. 2000;101:2734-41
Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function
Choi KM, et al, Circulation 2001;104:1101–7.
Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance.
Schwitter J, Arai AE. Eur Heart J. 2011 Apr;32(7):799-809. doi: 10.1093/eurheartj/ehq481. Epub 2011 Mar 11. Review
Cardiac magnetic resonance imaging to guide complex revascularization in stable coronary artery disease.
Morton G, Schuster A, Perera D, Nagel E. Eur Heart J. 2010 Sep;31(18):2209-15. doi: 10.1093/eurheartj/ehq256. Epub 2010 Aug 12. Review.
Revascularization in patients with chronic ischaemic myocardial dysfunction: insights from cardiovascular magnetic resonance imaging
Bondarenko O, Beek AM, McCann GP, van Rossum AC. Eur Heart J Cardiovasc Imaging. 2012 Dec;13(12):985-90
Cardiac magnetic resonance imaging: the new reference method for infarct characterization and prognostication after myocardial infarction?
Corocoran DS, Lee MM, Berry C. Eur Heart J Cardiovasc Imaging. 2014 Feb;15(2):130-2
MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial
Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H, Dill T, Larsson HB, Flamm SD, Marquardt M, Johansson L. Eur Heart J. 2008 Feb;29(4):480-9
MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial
Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, Schönberg SO, Luchner A, Strohm O, Ahlstrom H, Dill T, Hoebel N, Simor T; MR-IMPACT Investigators. Eur Heart J. 2013 Mar;34(10):775-81
Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial
Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S. Lancet. 2012 Feb 4;379(9814):453-60. doi: 10.1016/S0140-6736(11)61335-4. Epub 2011 Dec 22.
Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial
Greenwood JP, Motwani M, Maredia N, Brown JM, Everett CC, Nixon J, Bijsterveld P, Dickinson CJ, Ball SG, Plein S. Circulation. 2014 Mar 11;129(10):1129-38.
Prognostic Value of Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography in Suspected Coronary Heart Disease: Long-Term Follow-up of a Prospective, Diagnostic Accuracy Cohort Study
Greenwood JP, Herzog BA, Brown JM, Everett CC, Nixon J, Bijsterveld P, Maredia N, Motwani M, Dickinson CJ, Ball SG, Plein S. Ann Intern Med. 2016 May 10. doi: 10.7326/M15-1801.
Use of cardiovascular magnetic resonance imaging in acute coronary syndromes
Lockie T, Nagel E, Redwood S, Plein S. Circulation. 2009 Mar 31;119(12):1671-81. doi: 10.1161/CIRCULATIONAHA.108.816512
Distinction of salvaged and infarcted myocardium within the ischaemic area-at-risk with T2 mapping
Hammer-Hansen S, Ugander M, Hsu LY, Taylor J, Thune JJ, Køber L, Kellman P, Arai AE. Eur Heart J Cardiovasc Imaging. 2014 Sep;15(9):1048-53. doi: 10.1093/ehjci/jeu073
Myocardial disease (Cardiomyopathies, Myocarditis, and Non-ischaemic Heart Disease)
EACVI appropriateness criteria for the use of cardiovascular imaging in heart failure derived from European National Imaging Societies voting
Garbi M, Edvardsen T, Bax J, Petersen SE, McDonagh T, Filippatos G, Lancellotti P; Reviewer panel. Eur Heart J Cardiovasc Imaging 2016 Jul 17(7):711-21. doi: 10.1093/ehjci/jew081. Epub 2016 Apr 29.
2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR appropriate utilization of cardiovascular imaging in heart failure: a joint report of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Foundation Appropriate Use Criteria Task Force
Patel MR, White RD, Abbara S, Bluemke DA, Herfkens RJ, Picard M, Shaw LJ, Silver M, Stillman AE, Udelson J; American College of Radiology Appropriateness Criteria Committee; American College of Cardiology Foundation Appropriate Use Criteria Task Force. J Am Coll Cardiol. 2013 May 28;61(21):2207-31. doi: 10.1016/j.jacc.2013.02.005. Epub 2013 Apr 23
Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial
Lurz P, Luecke C, Eitel I, Föhrenbach F, Frank C, Grothoff M, de Waha S, Rommel KP, Lurz JA, Klingel K, Kandolf R, Schuler G, Thiele H, Gutberlet M. J Am Coll Cardiol. 2016 Apr 19;67(15):1800-11. doi: 10.1016/j.jacc.2016.02.013.
Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography
Leong DP, Chakrabarty A, Shipp N, Molaee P, Madsen PL, Joerg L, Sullivan T, Worthley SG, De Pasquale CG, Sanders P, Selvanayagam JB. Eur Heart J. 2012 Mar;33(5):640-8
The diagnostic performance of imaging methods in ARVC using the 2010 Task Force criteria
Borgquist R, Haugaa KH, Gilljam T, Bundgaard H, Hansen J, Eschen O, Jensen HK, Holst AG, Edvardsen T, Svendsen JH, Platonov PG. Eur Heart J Cardiovasc Imaging. 2014 Nov;15(11):1219-25
A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype
Ellims AH, Iles LM, Ling LH, Chong B, Macciocca I, Slavin GS, Hare JL, Kaye DM, Marasco SF, McLean CA, James PA, du Sart D, Taylor AJ. Eur Heart J Cardiovasc Imaging. 2014 Oct;15(10):1108-16.
Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy
Leonardi S, Raineri C, De Ferrari GM, Ghio S, Scelsi L, Pasotti M, Tagliani M, Valentini A, Dore R, Raisaro A, Arbustini E. Eur Heart J. 2009 Aug;30(16):2003-10.
Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy
Gruner C, Chan RH, Crean A, Rakowski H, Rowin EJ, Care M, Deva D, Williams L, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Siminovitch K, Ralph-Edwards AC, Rastegar H, Maron BJ, Maron MS. Eur Heart J. 2014 Oct 14;35(39):2706-13. doi: 10.1093/eurheartj/ehu154. Epub 2014 May 8.
T1 mapping and survival in systemic light-chain amyloidosis
Banypersad SM, Fontana M, Maestrini V, Sado DM, Captur G, Petrie A, Piechnik SK, Whelan CJ, Herrey AS, Gillmore JD, Lachmann HJ, Wechalekar AD, Hawkins PN, Moon JC. Eur Heart J. 2014 Nov 16. pii: ehu444
Takotsubo cardiomyopathy: an integrated multi-imaging approach
Bossone E, Lyon A, Citro R, Athanasiadis A, Meimoun P, Parodi G, Cimarelli S, Omerovic E, Ferrara F, Limongelli G, Cittadini A, Salerno-Uriarte JA, Perrone Filardi P, Schneider B, Sechtem U, Erbel R. Eur Heart J Cardiovasc Imaging. 2014 Apr;15(4):366-77.
Predictive value of CMR criteria for LV functional improvement in patients with acute myocarditis
Vermes E, Childs H, Faris P, Friedrich MG. Eur Heart J Cardiovasc Imaging. 2014 Oct;15(10):1140-4
Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis
Iles LM, Ellims AH, Llewellyn H, Hare JL, Kaye DM, McLean CA, Taylor AJ. Eur Heart J Cardiovasc Imaging. 2014 Oct 28.
T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy
Aus dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, Keller M, Schnabel PA, Giannitsis E, Korosoglou G, Katus HA, Steen H. Eur Heart J Cardiovasc Imaging. 2014
Cardiac magnetic resonance in hypertrophic cardiomyopathy
To AC, Dhillon A, Desai MY. JACC Cardiovasc Imaging. 2011 Oct;4(10):1123-37. doi: 10.1016/j.jcmg.2011.06.022. Review. Erratum in: JACC Cardiovasc Imaging. 2012 Apr;5(4):467
Sudden cardiac death prediction in hypertrophic cardiomyopathy using late gadolinium enhancement: trouble in paradise?
Jellis CL, Desai MY. Heart. 2014 Dec;100(23):1821-2. doi: 10.1136/heartjnl-2014-306295
Evaluation of the accuracy of gadolinium-enhanced CMR in the diagnosis of cardiac sarcoidosis
Smedema JP et al. J Am Coll Cardiol. 2005;45:1683-90.
CMR in cardiac amyloidosis
Maceira AM et al. Circulation. 2005;111:186-93.
CMR assessment of human myocarditis: a comparison to histology and molecular pathology
Mahrholdt H et al. Circulation. 2004;109:1250-8.
Importance of CMR within the Task Force Criteria for the diagnosis of ARVC in children and adolescents
Etoom Y, Govindapillai S, Hamilton R, Manlhiot C, Yoo SJ, Farhan M, Sarikouch S, Peters B, McCrindle BW, Grosse-Wortmann L. J Am Coll Cardiol. 2015 Mar 17;65(10):987-95. doi: 10.1016/j.jacc.2014.12.041.
Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update
te Riele AS, Tandri H, Bluemke DA. J Cardiovasc Magn Reson. 2014 Jul 20;16:50. doi: 10.1186/s12968-014-0050-8.
The role of cardiovascular magnetic resonance imaging in heart failure
Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer S. J Am Coll Cardiol. 2009 Oct 6;54(15):1407-24. doi: 10.1016/j.jacc.2009.04.094. Review.
Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy
Dass S, Suttie JJ, Piechnik SK, Ferreira VM, Holloway CJ, Banerjee R, Mahmod M, Cochlin L, Karamitsos TD, Robson MD, Watkins H, Neubauer S. Circ Cardiovasc Imaging. 2012 Nov;5(6):726-33. doi: 10.1161/CIRCIMAGING.112.976738.
Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis
Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, Whelan CJ, Myerson SG, Robson MD, Hawkins PN, Neubauer S, Moon JC. JACC Cardiovasc Imaging. 2013 Apr;6(4):488-97. doi: 10.1016/j.jcmg.2012.11.013
Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis
Luetkens JA, Homsi R, Sprinkart AM, Doerner J, Dabir D, Kuetting DL, Block W, Andrié R, Stehning C, Fimmers R, Gieseke J, Thomas DK, Schild HH, Naehle CP. Eur Heart J Cardiovasc Imaging. 2016 Feb;17(2):154-61. doi: 10.1093/ehjci/jev246. Epub 2015 Oct 16.
Predictive value of CMR criteria for LV functional improvement in patients with acute myocarditis
Vermes E, Childs H, Faris P, Friedrich MG. Eur Heart J Cardiovasc Imaging. 2014 Oct;15(10):1140-4. doi: 10.1093/ehjci/jeu099. Epub 2014 Jun 12.
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper
Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. J Am Coll Cardiol. 2009 Apr 28;53(17):1475-87. doi: 10.1016/j.jacc.2009.02.007.
Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy
Maron MS. J Cardiovasc Magn Reson. 2012 Feb 1;14:13. doi: 10.1186/1532-429X-14-13
Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance
Torreão JA, Ianni BM, Mady C, Naia E, Rassi CH, Nomura C, Parga JR, Avila LF, Ramires JA, Kalil-Filho R, Rochitte CE. J Cardiovasc Magn Reson. 2015 Nov 18;17:97. doi: 10.1186/s12968-015-0200-7.
Pericardium
European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease
Cosyns B, Plein S, Nihoyanopoulos P, Smiseth O, Achenbach S, Andrade MJ, Pepi M, Ristic A, Imazio M, Paelinck B, Lancellotti P; On behalf of the European Association of Cardiovascular Imaging (EACVI) and European Society of Cardiology Working Group (ESC WG) on Myocardial and Pericardial diseases. Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):12-31.
Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy
Francone M, Dymarkowski S, Kalantzi M, Rademakers FE, Bogaert J. Eur Radiol. 2006;16:944-51.
Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis
Alraies MC, AlJaroudi W, Yarmohammadi H, Yingchoncharoen T, Schuster A, Senapati A, Tariq M, Kwon D, Griffin BP, Klein AL. Am J Cardiol. 2015 Feb 15;115(4):542-7. doi: 10.1016/j.amjcard.2014.11.041.
Pericardial disease: value of CT and MR imaging
Bogaert J, Francone M. Radiology. 2013 May;267(2):340-56.
Cardiovascular magnetic resonance in pericardial diseases
Bogaert J, Francone M. J Cardiovasc Magn Reson. 2009 May 4;11:14. doi: 10.1186/1532-429X-11-14
Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation
Zurick AO, Bolen MA, Kwon DH, Tan CD, Popovic ZB, Rajeswaran J, Rodriguez ER, Flamm SD, Klein AL. JACC Cardiovasc Imaging. 2011 Nov;4(11):1180-91. doi: 10.1016/j.jcmg.2011.08.01
Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study
Feng D, Glockner J, Kim K, Martinez M, Syed IS, Araoz P, Breen J, Espinosa RE, Sundt T, Schaff HV, Oh JK. Circulation. 2011 Oct 25;124(17):1830-7. doi: 10.1161/CIRCULATIONAHA.111.026070.
Vascular disease
Cardiac magnetic resonance imaging of congenital bicuspid aortic valves and associated aortic pathologies in adults
Wassmuth R, von Knobelsdorff-Brenkenhoff F, Gruettner H, Utz W, Schulz-Menger J. Eur Heart J Cardiovasc Imaging. 2014 Jun;15(6):673-9
Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values
Burman ED, Keegan J, Kilner PJ. Circ Cardiovasc Imaging. 2008 Sep;1(2):104-13. doi: 10.1161/CIRCIMAGING.108.768911
Pulmonary artery diameters, cross sectional areas and area changes measured by cine cardiovascular magnetic resonance in healthy volunteers
Burman ED, Keegan J, Kilner PJ. J Cardiovasc Magn Reson. 2016 Mar 3;18:12. doi: 10.1186/s12968-016-0230-9
Magnetic resonance angiography: current status and future directions
Hartung MP, Grist TM, François CJ. J Cardiovasc Magn Reson. 2011 Mar 9;13:19. doi: 10.1186/1532-429X-13-19.
Cardiovascular magnetic resonance in pulmonary hypertension
Bradlow WM, Gibbs JS, Mohiaddin RH. J Cardiovasc Magn Reson. 2012 Jan 18;14:6. doi: 10.1186/1532-429X-14-6
Noninvasive estimation of PA pressure, flow, and resistance with CMRimaging: derivation and prospective validation study from the ASPIRE registry
Swift AJ, Rajaram S, Hurdman J, Hill C, Davies C, Sproson TW, Morton AC, Capener D, Elliot C, Condliffe R, Wild JM, Kiely DG. JACC Cardiovasc Imaging. 2013 Oct;6(10):1036-47. doi: 10.1016/j.jcmg.2013.01.013.
4D flow cardiovascular magnetic resonance consensus statement.
Dyverfeldt P, Bissell M, Barker AJ, Bolger AF, Carlhäll CJ, Ebbers T, Francios CJ, Frydrychowicz A, Geiger J, Giese D, Hope MD, Kilner PJ, Kozerke S, Myerson S, Neubauer S, Wieben O, Markl M. J Cardiovasc Magn Reson. 2015 Aug 10;17(1):72. doi: 10.1186/s12968-015-0174-5.
Valvular Heart Diseases
Heart valve disease: investigation by cardiovascular magnetic resonance
Myerson SG. J Cardiovasc Magn Reson. 2012 Jan 19;14:7. doi: 10.1186/1532-429X-14-7.
Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation
Cawley PJ, Maki JH, Otto CM. Circulation. 2009 Jan 27;119(3):468-78. doi: 10.1161/CIRCULATIONAHA.107.742486
Prognostic significance of LGE by CMR in aortic stenosis patients under going valve replacement
Barone-Rochette G, Piérard S, De Meester de Ravenstein C, Seldrum S, Melchior J, Maes F, Pouleur AC, Vancraeynest D, Pasquet A, Vanoverschelde JL, Gerber BL. J Am Coll Cardiol. 2014 Jul 15;64(2):144-54. doi: 10.1016/j.jacc.2014.02.612
Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome
Myerson SG, d'Arcy J, Mohiaddin R, Greenwood JP, Karamitsos TD, Francis JM, Banning AP, Christiansen JP, Neubauer S. Circulation. 2012 Sep 18;126(12):1452-60. doi: 10.1161/CIRCULATIONAHA.111.083600
Determination of Clinical Outcome in Mitral Regurgitation With Cardiovascular Magnetic Resonance Quantitation
Myerson SG, d'Arcy J, Christiansen JP, Dobson LE, Mohiaddin R, Francis JM, Prendergast B, Greenwood JP, Karamitsos TD, Neubauer S. Circulation. 2016 May 17. pii: CIRCULATIONAHA.115.017888
Cardiac masses/tumors
MR imaging of cardiac tumors and masses: a review of methods and clinical applications
Motwani M, Kidambi A, Herzog BA, Uddin A, Greenwood JP, Plein S. Radiology. 2013 Jul;268(1):26-43. doi: 10.1148/radiol.13121239
Cardiovascular magnetic resonance imaging for diagnosis and clinical management of suspected cardiac masses and tumours
Fussen S, De Boeck BW, Zellweger MJ, Bremerich J, Goetschalckx K, Zuber M, Buser PT. Eur Heart J. 2011 Jun;32(12):1551-60. doi: 10.1093/eurheartj/ehr104. Epub 2011 Apr 15.
Congenital Heart Disease (and Adult Congenital Heart Disease)
Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology
Kilner PJ, Geva T, Kaemmerer H, Trindade PT, Schwitter J, Webb GD. Eur Heart J. 2010 Apr;31(7):794-805.
Indications for cardiovascular magnetic resonance in children with congenital and acquired heart disease: an expert consensus paper of theImaging Working Group of the AEPC and the Cardiovascular MagneticResonance Section of the EACVI
Valsangiacomo Buechel ER, Grosse-Wortmann L, Fratz S, Eichhorn J, Sarikouch S, Greil GF, Beerbaum P, Bucciarelli-Ducci C, Bonello B, Sieverding L, Schwitter J, Helbing WA; EACVI, Galderisi M, Miller O, Sicari R, Rosa J, Thaulow E, Edvardsen T, Brockmeier K, Qureshi S, Stein J. Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):281-97. doi: 10.1093/ehjci/jeu129. Epub 2015 Feb 17.
Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease
Fratz S, Chung T, Greil GF, Samyn MM, Taylor AM, Valsangiacomo Buechel ER, Yoo SJ, Powell AJ. J Cardiovasc Magn Reson. 2013 Jun 13;15:51. doi: 10.1186/1532-429X-15-51
Imaging of congenital heart disease in adults.
Babu-Narayan SV, Giannakoulas G, Valente AM, Li W, Gatzoulis MA. Eur Heart J. 2016 Apr 14;37(15):1182-95. doi: 10.1093/eurheartj/ehv519. Epub 2015 Sep 29.
Incidental findings
Extra-cardiac findings in cardiovascular magnetic resonance: what the imaging cardiologist needs to know
Rodrigues JC, Lyen SM, Loughborough W, Amadu AM, Baritussio A, Dastidar AG, Manghat NE, Bucciarelli-Ducci C. J Cardiovasc Magn Reson. 2016 May 9;18(1):26. doi: 10.1186/s12968-016-0246-1
Incidental extra-cardiac findings on clinical CMR
Irwin RB, Newton T, Peebles C, Borg A, Clark D, Miller C, Abidin N, Greaves M, Schmitt M. Eur Heart J Cardiovasc Imaging. 2013 Feb;14(2):158-66. doi: 10.1093/ehjci/jes133
Novel techniques
T1-mapping
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB; Society for Cardiovascular Magnetic Resonance Imaging; Cardiovascular Magnetic Resonance Working Group of the European Society of Cardiology. J Cardiovasc Magn Reson. 2013 Oct 14;15:92. doi: 10.1186/1532-429X-15-92.
Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review
Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S. J Cardiovasc Magn Reson. 2016 Nov 30;18(1):89.
4D-flow
4D flow cardiovascular magnetic resonance consensus statement
Dyverfeldt P, Bissell M, Barker AJ, Bolger AF, Carlhäll CJ, Ebbers T, Francios CJ, Frydrychowicz A, Geiger J, Giese D, Hope MD, Kilner PJ, Kozerke S, Myerson S, Neubauer S, Wieben O, Markl M. J Cardiovasc Magn Reson. 2015 Aug 10;17:72. doi: 10.1186/s12968-015-0174-5
Advanced Analysis Techniques for Intra-cardiac Flow Evaluation from 4D Flow MRI
van der Geest RJ, Garg P. Curr Radiol Rep. 2016;4:38
Feature-tracking
Cardiovascular magnetic resonance myocardial feature tracking: concepts and clinical applications
Schuster A, Hor KN, Kowallick JT, Beerbaum P, Kutty S. Circ Cardiovasc Imaging. 2016 Apr 9(4):e004077. doi: 10.1161/CIRCIMAGING.115.004077.
Principles of cardiovascular magnetic resonance feature tracking and echocardiographic speckle tracking for informed clinical use
Pedrizzetti G, Claus P, Kilner PJ, Nagel E. J Cardiovasc Magn Reson. 2016 Aug 26;18(1):51. doi: 10.1186/s12968-016-0269-7.
Online resources
EACVI exclusive CMR e-learning course - NEW!
- NOW LIVE! Practical and comprehensive training in an engaging format.
- Exclusive online course to become an expert in CMR & prepared for EACVI Certification.
- 10 exclusive tutorials dedicated to the practice of CMR, covering all aspects from indications to methods, how-to scanning and post-processing, for cardiovascular imagers wanting to learn CMR, or more experienced CMR practitioners seeking expert opinion.
EACVI Congress Resources - Selected by HIT
MRI section (mid way down page). A selection of CMR related webcasts based on presentations at prior EuroCMR, EuroEcho-Imaging and ESC Congresses
EACVI endorsed CMR Pocket Guides & Mobile App
These pocket guides aim at providing a day-to-day companion for those new to CMR and for those looking for a quick reference guide in routine practice
- Cardiovascular Magnetic Resonance Pocket Guide & App - NEW VERSION 2016!
- Congenital Heart Disease Pocket Guide
- Physics for Clinicians
SCMR online-learning (SCMR members only)
Comprehensive online learning library based on video presentations from priro SCMR congresses. Covers general principles, physics, instrumentation and clinical applications of CMR. http://scmr.peachnewmedia.com/store/provider/provider09.php
SCMR Case of the Week (Available for members and non-members)
This library of cases is a useful repository of interesting, useful and sometimes beautiful cases demonstrating CMR as a clinical and research technique and acting a reference library.
SCMR "How I Do" Series (SCMR Members only).
A series of downloadable video and slide resources covering CMR safety, volume study, and how to CMR the aorta:
- "How I Do" CMR Scanning Safely (Elisabeth Burman, Royal Brompton Hospital, UK)
- "How I Do" a CMR Volume Study (James Moon, The Heart Hospital, London)
- "How I do Iron overload and Thalassemia" (Mark Westwood, The Heart Hospital, London)
- "How we do CMR in acute infarction" (Derek Hausenloy, The Heart Hospital, London)
- "How I do CMR of valvular heart disease" (Saul Myerson, Oxford CMR unit)
- "How I do CMR of the Aorta" (Saul Myerson, Oxford CMR unit)
- "How I do" CMR of repaired Tetralogy of Fallot (Sonya Babu-Narayan, Royal Brompton Hospital)
- "How I do" CMR after atrial redirection surgery (Sonya Babu-Narayan, Royal Brompton Hospital)
- "How I do" anomalous coronaries (Gavin Bainbridge, Sven Plein, John Greenwood, Leeds)
- Late enhancement imaging quiz, provided by James Moon — Questions here, Answers here
- "How we do Dobutamine Stress CMR" (Ashraf Hamdan, Ingo Paetsch and Eike Nagel)
- "How we do Perfusion CMR" (Robert Manka, Rolf Gebker, Eike Nagel)
- "How I do" CMR in DCM (Sanjay Prasad, Royal Brompton Hospital)
- "How I do" CMR in HCM (Sanjay Prasad, Royal Brompton Hospital)
- "How I Do" CMR of ARVC/D (David A. Bluemke, Johns Hopkins)
- "How we do Perform Delayed Enhancement Imaging"(Ray Kim and Bob Judd, Duke University)
- "How I Do" Myocardial Perfusion (Christopher Klassen and Norbert Wilke, University of Florida Health Science Center)
Our mission: To reduce the burden of cardiovascular disease.